37707 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 30
00:14 UTC
|
CABO
Cable One
|
◎ Target | Sam McHugh ★★☆☆☆ #2647 | Neutral | $40.00→ $13.00-67.5% |
|
Sep 30
00:14 UTC
|
BROS
Dutch Bros
|
◎ Target | John Ivankoe ★★★☆☆ #1695 | Overweight | $75.00→ $60.00-20.0% |
|
Sep 30
00:14 UTC
|
BROS
Dutch Bros
|
◎ Target | John Ivankoe ★★★☆☆ #1695 | Overweight | $75.00→ $60.00-20.0% |
|
Sep 30
00:14 UTC
|
BRKR
Bruker
|
◎ Target | Puneet Souda ★★★★★ #20 | Outperform | $60.00→ $80.00+33.3% |
|
Sep 30
00:14 UTC
|
BOOT
Boot Barn
|
◎ Target | Jeremy Hamblin ★★★☆☆ #1749 | Buy | $235.00→ $224.00-4.7% |
|
Sep 30
00:14 UTC
|
BOOT
Boot Barn
|
◎ Target | Jonathan Komp ★★☆☆☆ #2813 | Outperform | $212.00→ $160.00-24.5% |
|
Sep 30
00:14 UTC
|
BLSH
Bullish
|
◎ Target | Bill Papanastasiou ★☆☆☆☆ #3030 | Market Perform | $55.00→ $40.00-27.3% |
|
Sep 30
00:14 UTC
|
BKR
Baker Hughes
|
◎ Target | Lloyd Byrne ★★★★☆ #718 | Buy | $80.00→ $77.00-3.8% |
|
Sep 30
00:14 UTC
|
BE
Bloom Energy
|
◎ Target | Julien Dumoulin-Smith not yet tracked | Hold | $229.00→ $264.00+15.3% |
|
Sep 30
00:14 UTC
|
AYI
Acuity
|
◎ Target | Timothy Wojs ★★☆☆☆ #2406 | Neutral | $390.00→ $360.00-7.7% |
|
Sep 30
00:14 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | David Hoang ★★☆☆☆ #2531 | Buy | $280.00→ $267.00-4.6% |
|
Sep 30
00:14 UTC
|
AIR
AAR
|
◎ Target | Sheila Kahyaoglu ★★☆☆☆ #2339 | Buy | $155.00→ $160.00+3.2% |
|
Sep 30
00:14 UTC
|
AGX
Argan
|
◎ Target | Michael Fairbanks ★★★☆☆ #1595 | Overweight | $800.00→ $785.00-1.9% |
|
Sep 30
00:14 UTC
|
AEO
American Eagle Outfitters
|
◎ Target | Kelly Crago ★★★★☆ #500 | Market Perform | $18.00→ $20.00+11.1% |
|
Sep 29
21:13 UTC
|
AIR
AAR
|
◎ Target | Sheila Kahyaoglu ★★☆☆☆ #2339 | Buy | $155.00→ $160.00+3.2% |
|
Sep 29
20:13 UTC
|
VALE
Vale
|
◎ Target | Myles Allsop ★★★☆☆ #1298 | Neutral | $16.50→ $15.00-9.1% |
|
Sep 29
20:13 UTC
|
PRM
Perimeter Solutions
|
◎ Target | Joshua Spector ★★★☆☆ #1916 | Buy | $42.00→ $38.00-9.5% |
|
Sep 29
20:13 UTC
|
NESR
National Energy Services Reunited
|
◎ Target | Josh Silverstein ★★★☆☆ #1367 | Buy | $47.00→ $46.00-2.1% |
|
Sep 29
19:13 UTC
|
VIPS
Vipshop
|
◎ Target | Alicia Yap ★☆☆☆☆ #3105 | Neutral | $15.30→ $13.00-15.0% |
|
Sep 29
19:13 UTC
|
PAGS
PagSeguro Digital
|
◎ Target | Kaio Prato not yet tracked | Buy | $12.50→ $11.00-12.0% |
|
Sep 29
19:13 UTC
|
NBIX
Neurocrine Biosciences
|
◎ Target | Ashwani Verma ★★★★☆ #479 | Buy | $231.00→ $214.00-7.4% |
|
Sep 29
19:13 UTC
|
ENPH
Enphase Energy
|
◎ Target | Vikram Bagri ★☆☆☆☆ #3011 | Neutral | $40.00→ $37.00-7.5% |
|
Sep 29
18:13 UTC
|
XP
XP
|
◎ Target | Gustavo Schroden ★★★★☆ #455 | Buy | $23.00→ $25.00+8.7% |
|
Sep 29
18:13 UTC
|
ROL
Rollins
|
◎ Target | Toni Kaplan ★★★★☆ #546 | Overweight | $60.00→ $45.00-25.0% |
|
Sep 29
18:13 UTC
|
OKTA
Okta
|
◎ Target | Meta Marshall ★★★★☆ #553 | Overweight | $200.00→ $245.00+22.5% |
|
Sep 29
18:13 UTC
|
NXRT
NexPoint Residential Trust
|
◎ Target | Michael Lewis ★★★☆☆ #1419 | Hold | $26.00→ $18.00-30.8% |
|
Sep 29
18:13 UTC
|
MNR
Mach Natural Resources
|
◎ Target | John Freeman ★★★★☆ #356 | Strong-Buy | $19.00→ $16.00-15.8% |
|
Sep 29
18:13 UTC
|
KIM
Kimco Realty
|
◎ Target | Ronald Kamdem ★★★☆☆ #1776 | Equal Weight | $24.00→ $25.00+4.2% |
|
Sep 29
18:13 UTC
|
IMMX
Immix Biopharma
|
◎ Target | Gil Blum ★★★☆☆ #2243 | Buy | $21.00→ $30.00+42.9% |
|
Sep 29
18:13 UTC
|
DCI
Donaldson
|
◎ Target | Angel Castillo ★★☆☆☆ #2391 | Equal Weight | $91.00→ $95.00+4.4% |
|
Sep 29
17:13 UTC
|
TXG
10x Genomics
|
◎ Target | Mike Kratky ★★★☆☆ #1263 | Market Perform | $40.00→ $90.00+125.0% |
|
Sep 29
17:13 UTC
|
TWST
Twist Bioscience
|
◎ Target | Puneet Souda ★★★★★ #20 | Outperform | $160.00→ $190.00+18.8% |
|
Sep 29
17:13 UTC
|
MTN
Vail Resorts
|
◎ Target | Patrick Scholes ★★★☆☆ #1059 | Buy | $195.00→ $191.00-2.1% |
|
Sep 29
17:13 UTC
|
MTN
Vail Resorts
|
◎ Target | Matthew Boss ★★★☆☆ #1270 | Neutral | $126.00→ $150.00+19.0% |
|
Sep 29
17:13 UTC
|
JEF
Jefferies Financial Group
|
◎ Target | Chris Kotowski ★★★★☆ #841 | Outperform | $76.00→ $71.00-6.6% |
|
Sep 29
17:13 UTC
|
ILMN
Illumina
|
◎ Target | Puneet Souda ★★★★★ #20 | Outperform | $220.00→ $300.00+36.4% |
|
Sep 29
17:13 UTC
|
EQT
EQT
|
◎ Target | Lloyd Byrne ★★★★☆ #718 | Buy | $75.00→ $73.00-2.7% |
|
Sep 29
17:13 UTC
|
BRKR
Bruker
|
◎ Target | Puneet Souda ★★★★★ #20 | Outperform | $60.00→ $80.00+33.3% |
|
Sep 29
17:13 UTC
|
BKR
Baker Hughes
|
◎ Target | Lloyd Byrne ★★★★☆ #718 | Buy | $80.00→ $77.00-3.8% |
|
Sep 29
16:13 UTC
|
UNCY
Unicycive Therapeutics
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2816 | Buy | $15.00→ $13.00-13.3% |
|
Sep 29
16:13 UTC
|
OPRX
OptimizeRx
|
◎ Target | Anderson Schock ★★★☆☆ #993 | Buy | $10.00→ $11.00+10.0% |
|
Sep 29
16:13 UTC
|
NUAI
New Era Energy & Digital
|
◎ Target | Nick Giles ★☆☆☆☆ #3212 | Buy | $10.00→ $13.00+30.0% |
|
Sep 29
16:13 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Louise Chen ★★★☆☆ #1364 | Sec→ r Outperform | $155.00→ $180.00+16.1% |
|
Sep 29
16:13 UTC
|
IREN
IREN
|
◎ Target | Lucas Pipes not yet tracked | Buy | $96.00→ $91.00-5.2% |
|
Sep 29
15:13 UTC
|
YUM
Yum! Brands
|
◎ Target | John Ivankoe ★★★☆☆ #1695 | Overweight | $160.00→ $150.00-6.2% |
|
Sep 29
15:13 UTC
|
USFD
US Foods
|
◎ Target | John Ivankoe ★★★☆☆ #1695 | Neutral | $108.00→ $98.00-9.3% |
|
Sep 29
15:13 UTC
|
TXRH
Texas Roadhouse
|
◎ Target | John Ivankoe ★★★☆☆ #1695 | Neutral | $202.00→ $200.00-1.0% |
|
Sep 29
15:13 UTC
|
SYY
Sysco
|
◎ Target | John Ivankoe ★★★☆☆ #1695 | Overweight | $100.00→ $95.00-5.0% |
|
Sep 29
15:13 UTC
|
SHAK
Shake Shack
|
◎ Target | John Ivankoe ★★★☆☆ #1695 | Neutral | $77.00→ $75.00-2.6% |
|
Sep 29
15:13 UTC
|
SBUX
Starbucks
|
◎ Target | John Ivankoe ★★★☆☆ #1695 | Overweight | $112.00→ $105.00-6.2% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.